State Street Corp Purchases 83,395 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

State Street Corp raised its position in Option Care Health, Inc. (NASDAQ:OPCH) by 1.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,257,172 shares of the company’s stock after buying an additional 83,395 shares during the quarter. State Street Corp owned about 3.68% of Option Care Health worth $195,849,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. FMR LLC increased its stake in Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after acquiring an additional 4,304,896 shares during the last quarter. Westfield Capital Management Co. LP increased its stake in shares of Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after purchasing an additional 599,589 shares during the last quarter. Thrivent Financial for Lutherans lifted its position in shares of Option Care Health by 7.4% during the 3rd quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock worth $183,541,000 after buying an additional 404,811 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Option Care Health by 6.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock worth $99,870,000 after buying an additional 218,844 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its stake in Option Care Health by 2.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,518,923 shares of the company’s stock valued at $78,842,000 after buying an additional 63,955 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and reduced their price target for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Barrington Research lowered their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and cut their price objective for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Finally, JMP Securities increased their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $30.14.

Option Care Health Trading Down 1.1 %

NASDAQ OPCH opened at $23.39 on Friday. The firm has a market capitalization of $3.98 billion, a PE ratio of 19.66, a price-to-earnings-growth ratio of 2.37 and a beta of 1.33. The business’s 50-day moving average price is $25.51 and its two-hundred day moving average price is $28.51. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.64% of the stock is currently owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.